| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
|
Goff, Donald C.
|
|
2005
|
80 |
1 |
p. 45-53
9 p.
|
artikel
|
| 2 |
Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: A systematic review of randomized trials
|
Rummel, Christine
|
|
2005
|
80 |
1 |
p. 85-97
13 p.
|
artikel
|
| 3 |
Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial
|
Miller, Del D.
|
|
2005
|
80 |
1 |
p. 33-43
11 p.
|
artikel
|
| 4 |
Corrigendum to “Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores” [Schizophrenia Research 71 (1) (2004) 155–165]
|
Lenert, Leslie A.
|
|
2005
|
80 |
1 |
p. 135-136
2 p.
|
artikel
|
| 5 |
Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial
|
Stroup, Scott
|
|
2005
|
80 |
1 |
p. 1-8
8 p.
|
artikel
|
| 6 |
Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS)
|
Singh, Swaran P.
|
|
2005
|
80 |
1 |
p. 117-130
14 p.
|
artikel
|
| 7 |
Early warning signs of relapse following a first episode of psychosis
|
Gleeson, John F.
|
|
2005
|
80 |
1 |
p. 107-111
5 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2005
|
80 |
1 |
p. CO2-
1 p.
|
artikel
|
| 9 |
Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia
|
McCormick, Laurie
|
|
2005
|
80 |
1 |
p. 73-84
12 p.
|
artikel
|
| 10 |
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia
|
Molina, Vicente
|
|
2005
|
80 |
1 |
p. 61-71
11 p.
|
artikel
|
| 11 |
Persistent psychoses in first episode patients
|
Manchanda, Rahul
|
|
2005
|
80 |
1 |
p. 113-116
4 p.
|
artikel
|
| 12 |
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
|
McEvoy, Joseph P.
|
|
2005
|
80 |
1 |
p. 19-32
14 p.
|
artikel
|
| 13 |
Serum lipid profiles and schizophrenia: Effects of conventional or atypical antipsychotic drugs in Taiwan
|
Huang, Tiao-Lai
|
|
2005
|
80 |
1 |
p. 55-59
5 p.
|
artikel
|
| 14 |
The CATIE schizophrenia effectiveness trial
|
DeLisi, L.E.
|
|
2005
|
80 |
1 |
p. v-vi
nvt p.
|
artikel
|
| 15 |
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
|
Meyer, Jonathan M.
|
|
2005
|
80 |
1 |
p. 9-18
10 p.
|
artikel
|
| 16 |
The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow up study
|
Rémillard, Sophie
|
|
2005
|
80 |
1 |
p. 99-106
8 p.
|
artikel
|
| 17 |
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders
|
Sengupta, Sarojini M.
|
|
2005
|
80 |
1 |
p. 131-133
3 p.
|
artikel
|
Tijdschrift beschrijving